H2S during circulatory shock: Some unresolved questions

Nitric Oxide - Biology and Chemistry

Volumn 41, Issue , 2014, Pages 48-61

  McCook, Oscar ^a   Radermacher, Peter ^a   Volani, Chiara ^a   Asfar, Pierre ^b   Ignatius, Anita ^a   Kemmler, Julia ^a   Möller, Peter ^a   Szabó, Csaba ^c   Whiteman, Matthew ^d   Woodg, Mark E ^e   Wang, Rui ^f   Georgieff, Michael ^a   Wachter, Ulrich ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c University of Texas Medical Branch School of Medicine   (United States)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF EXETER   (United Kingdom)

^f LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Cystathione b synthase; Cystathionine c lyase; GYY4137; Na2S; NaSH

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; LYASE; UNCLASSIFIED DRUG; SODIUM BISULFIDE; SODIUM SULFIDE; SULFIDE;

ACUTE LIVER FAILURE; BLEEDING; BLOOD LEVEL; BURN; CHRONIC DISEASE; COMORBIDITY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; HEART FAILURE; HUMAN; KIDNEY FUNCTION; KIDNEY ISCHEMIA; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SEPSIS; SHOCK; ANIMAL; BLOOD; CLINICAL CHEMISTRY; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PIG; RAT;

ANIMALIA;

ANIMALS; CLINICAL CHEMISTRY TESTS; HUMANS; HYDROGEN SULFIDE; MICE; RATS; SHOCK; SULFIDES; SWINE;

EID: 84907597803     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2014.03.163     Document Type: Review

References (124)

1. 2S induces a suspended animationlike state in mice, Science 308 (2005) 518.
2. G.P. Volpato, R. Searles, B. Yu, M. Scherrer-Crosbie, K.D. Bloch, F. Ichinose, W.M. Zapol, Inhaled hydrogen sulfide: A rapidly reversible inhibitor of cardiac and metabolic function in the mouse, Anesthesiology 108 (2008) 659-668.
3. E. Blackstone, M.B. Roth, Suspended animation-like state protects mice from lethal hypoxia, Shock 27 (2007) 370-372.
4. E.M. Bos, R. Wang, P.M. Snijder, M. Boersema, J. Damman, M. Fu, J. Moser, J.L. Hillebrands, R.J. Ploeg, G. Yang, H.G.D. Leuvenink, H. van Goor, Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress, J. Am. Soc. Nephrol. 24 (2013) 759-770.
5. J. Cui, L. Liu, J. Zou, W. Qiao, H. Liu, Y. Qi, C. Yan, Protective effect of endogenous hydrogen sulfide against oxidative stress in gastric ischemia- reperfusion injury, Exp. Ther. Med. 5 (2013) 689-694.
6. J. Wu, J. Wei, X. You, X. Chen, H. Zhu, X. Zhu, Y. Liu, M. Xu, Inhibition of hydrogen sulfide generation contributes to lung injury after experimental orthotopic lung transplantation, J. Surg. Res. 182 (2013) e25-e33.
7. E.M. Bos, P.M. Snijder, H. Jekel, M. Weij, J.C. Leemans, M.C.F. van Dijk, J.L. Hillebrands, T. Lisman, H. van Goor, H.G.D. Leuvenink, Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury, Transpl. Int. 25 (2012) 897-908.
8. J.P. Hunter, S.A. Hosgood, M. Patel, R. Rose, K. Read, M.L. Nicholson, Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury, Br. J. Surg. 99 (2012) 1665-1671.
9. I. Lobb, A. Mok, Z. Lan, W. Liu, B. Garcia, A. Sener, Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation, BJU Int. 110 (2012) E1187-E1195.
10. B.L. Predmore, K. Kondo, S. Bhushan, M.A. Zlatopolsky, A.L. King, J.P. Aragon, D.B. Grinsfelder, M.E. Condit, D.J. Lefer, The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability, Am. J. Physiol. Heart Circ. Physiol. 302 (2012) H2410-H2418.
11. Y. Gao, X. Yao, Y. Zhang, W. Li, K. Kang, L. Sun, X. Sun, The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats, Int. J. Cardiol. 152 (2011) 177-183.
12. F. Simon, A. Scheuerle, M. Groger, B. Stahl, U. Wachter, J. Vogt, G. Speit, B. Hauser, P. Moller, E. Calzia, C. Szabo, H. Schelzig, M. Georgieff, P. Radermacher, F. Wagner, Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury, Shock 35 (2011) 156-163.
13. P.W. Henderson, S.P. Singh, A.L. Weinstein, V. Nagineni, D.C. Rafii, D. Kadouch, D.D. Krijgh, J.A. Spector, Therapeutic metabolic inhibition: hydrogen sulfide significantly mitigates skeletal muscle ischemia reperfusion injury in vitro and in vivo, Plast. Reconstr. Surg. 126 (2010) 1890-1898.
14. S.A. Hosgood, M.L. Nicholson, Hydrogen sulphide ameliorates ischaemia- reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation, Br. J. Surg. 97 (2010) 202-209.
15. R.M. Osipov, M.P. Robich, J. Feng, V. Chan, R.T. Clements, R.J. Deyo, C. Szabo, F.W. Sellke, Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass, Interact. Cardiovasc. Thorac. Surg. 10 (2010) 506-512.
16. E.M. Bos, H.G. Leuvenink, P.M. Snijder, N.J. Kloosterhuis, J.L. Hillebrands, J.C. Leemans, S. Florquin, H. van Goor, Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury, J. Am. Soc. Nephrol. 20 (2009) 1901-1905.
17. K. Kang, M. Zhao, H. Jiang, G. Tan, S. Pan, X. Sun, Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats, Liver Transpl. 15 (2009) 1306-1314.
18. R.M. Osipov, M.P. Robich, J. Feng, Y. Liu, R.T. Clements, H.P. Glazer, N.R. Sodha, C. Szabo, C. Bianchi, F.W. Sellke, Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection, J. Cardiovasc. Pharmacol. 54 (2009) 287-297.
19. N.R. Sodha, R.T. Clements, J. Feng, Y. Liu, C. Bianchi, E.M. Horvath, C. Szabo, G.L. Stahl, F.W. Sellke, Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury, J. Thorac. Cardiovasc. Surg. 138 (2009) 977-984.
20. P. Tripatara, N.S. Patel, V. Brancaleone, D. Renshaw, J. Rocha, B. Sepodes, H. Mota-Filipe, M. Perretti, C. Thiemermann, Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: An in vivo study, Eur. J. Pharmacol. 606 (2009) 205-209.
21. Z. Xu, G. Prathapasinghe, N. Wu, S.Y. Hwang, Y.L. Siow, K. O, Ischemia- reperfusion reduces cystathionine-b-synthase-mediated hydrogen sulfide generation in the kidney, Am. J. Physiol. Renal. Physiol. 297 (2009) F27-F35.
22. B. Florian, R. Vintilescu, A.T. Balseanu, A.M. Buga, O. Grisk, L.C. Walker, C. Kessler, A. Popa-Wagner, Long-term hypothermia reduces infarct volume in aged rats after focal ischemia, Neurosci. Lett. 438 (2008) 180-185.
23. Z. Fu, X. Liu, B. Geng, L. Fang, C. Tang, Hydrogen sulfide protects rat lung from ischemia-reperfusion injury, Life Sci. 82 (2008) 1196-1202.
24. S. Jha, J.W. Calvert, M.R. Duranski, A. Ramachandran, D.J. Lefer, Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling, Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H801-H806.
25. F. Simon, R. Giudici, C.N. Duy, H. Schelzig, S. Oter, M. Groger, U. Wachter, J. Vogt, G. Speit, C. Szabo, P. Radermacher, E. Calzia, Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury, Shock 30 (2008) 359-364.
26. N.R. Sodha, R.T. Clements, J. Feng, Y. Liu, C. Bianchi, E.M. Horvath, C. Szabo, F.W. Sellke, The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury, Eur. J. Cardiothorac. Surg. 33 (2008) 906-913.
27. P. Tripatara, N.S. Patel, M. Collino, M. Gallicchio, J. Kieswich, S. Castiglia, E. Benetti, K.N. Stewart, P.A. Brown, M.M. Yaqoob, R. Fantozzi, C. Thiemermann, Generation of endogenous hydrogen sulfide by cystathionine-lyase limits renal ischemia/reperfusion injury and dysfunction, Lab. Invest. 88 (2008) 1038-1048.
28. J.W. Elrod, J.W. Calvert, J. Morrison, J.E. Doeller, D.W. Kraus, L. Tao, X. Jiao, R. Scalia, L. Kiss, C. Szabo, H. Kimura, C.W. Chow, D.J. Lefer, Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function, Proc. Natl. Acad. Sci. USA 104 (2007) 15560-15565.
29. J.S. Bian, Q.C. Yong, T.T. Pan, Z.N. Feng, M.Y. Ali, S. Zhou, P.K. Moore, Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes, J. Pharmacol. Exp. Ther. 316 (2006) 670-678.
30. D. Johansen, K. Ytrehus, G.F. Baxter, Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury. Evidence for a role of KATP channels, Basic Res. Cardiol. 101 (2006) 53-60.
31. H. Pan, D. Chen, B. Liu, X. Xie, J. Zhang, G. Yang, Effects of sodium hydrosulfide on intestinal mucosal injury in a rat model of cardiac arrest and cardiopulmonary resuscitation, Life Sci. 93 (2013) 24-29.
32. K. Kida, S. Minamishima, H. Wang, J. Ren, K. Yigitkanli, A. Nozari, J.B. Mandeville, P.K. Liu, C.H. Liu, F. Ichinose, Sodium sulfide prevents water diffusion abnormality in the brain and improves long term outcome after cardiac arrest in mice, Resuscitation 83 (2012) 1292-1297.
33. X. Wei, L. Duan, L. Bai, M. Tian, W. Li, B. Zhang, Effects of exogenous hydrogen sulfide on brain metabolism and early neurological function in rabbits after cardiac arrest, Intensive Care Med. 38 (2012) 1877-1885.
34. J. Knapp, A. Heinzmann, A. Schneider, S.A. Padosch, B.W. Bottiger, P. Teschendorf, E. Popp, Hypothermia and neuroprotection by sulfide after cardiac arrest and cardiopulmonary resuscitation, Resuscitation 82 (2011) 1076-1080.
35. M. Derwall, M. Westerkamp, C. Lower, J. Deike-Glindemann, N.K. Schnorrenberger, M. Coburn, K.W. Nolte, N. Gaisa, J. Weis, K. Siepmann, M. Hausler, R. Rossaint, M. Fries, Hydrogen sulfide does not increase resuscitability in a porcine model of prolonged cardiac arrest, Shock 34 (2010) 190-195.
36. S. Minamishima, M. Bougaki, P.Y. Sips, J.D. Yu, Y.A. Minamishima, J.W. Elrod, D.J. Lefer, K.D. Bloch, F. Ichinose, Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice, Circulation 120 (2009) 888-896.
37. K. Issa, A. Kimmoun, S. Collin, C. Strub, F. Ganster, S. Fremont-Orlowski, P. Asfar, P. Lacolley, P.M. Mertes, B. Levy, Endogenous production and exogenous administration of hydrogen sulfide protects against ischaemia- reperfusion injury, Crit. Care 17 (2013) R139.
38. H. Bracht, A. Scheuerle, M. Groger, B. Hauser, J. Matallo, O. McCook, A. Seifritz, U. Wachter, J.A. Vogt, P. Asfar, M. Matejovic, P. Moller, E. Calzia, C. Szabo, W. Stahl, K. Hoppe, B. Stahl, L. Lampl, M. Georgieff, F. Wagner, P. Radermacher, F. Simon, Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock, Crit. Care Med. 40 (2012) 2157-2167.
39. W. Chai, Y. Wang, J.Y. Lin, X.D. Sun, L.N. Yao, Y.H. Yang, H. Zhao, W. Jiang, C.J. Gao, Q. Ding, Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress, J. Surg. Res. 176 (2012) 210-219.
40. 2S in hemorrhagic shock in rats, Crit. Care 16 (2012) R178.
41. T. Drabek, P.M. Kochanek, J. Stezoski, X. Wu, H. Bayir, R.C. Morhard, S.W. Stezoski, S.A. Tisherman, Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs, Shock 35 (2011) 67-73.
42. F. Ganster, M. Burban, M. de la Bourdonnaye, L. Fizanne, O. Douay, L. Loufrani, A. Mercat, P. Cales, P. Radermacher, D. Henrion, P. Asfar, F. Meziani, Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats, Crit. Care 14 (2010) R165.
43. Y.Y. Mok, P.K. Moore, Hydrogen sulphide is pro-inflammatory in haemorrhagic shock, Inflamm. Res. 57 (2008) 512-518.
44. M.L. Morrison, J.E. Blackwood, S.L. Lockett, A. Iwata, R.K. Winn, M.B. Roth, Surviving blood loss using hydrogen sulfide, J. Trauma 65 (2008) 183-188.
45. Y.Y. Mok, M.S. Atan, C. Yoke Ping, W. Zhong Jing, M. Bhatia, S. Moochhala, P.K. Moore, Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis, Br. J. Pharmacol. 143 (2004) 881-889.
46. D.H. Seitz, J.S. Froba, U. Niesler, A. Palmer, H.A. Veltkamp, S.T. Braumuller, F. Wagner, K. Wagner, S. Bader, U. Wachter, E. Calzia, P. Radermacher, M.S. Huber-Lang, S. Zhou, F. Gebhard, M.W. Knoferl, Inhaled hydrogen sulfide induces suspended animation, but does not alter the inflammatory response after blunt chest trauma, Shock 37 (2012) 197-204.
47. F. Wagner, A. Scheuerle, S. Weber, B. Stahl, O. McCook, M.W. Knoferl, M. Huber-Lang, D.H. Seitz, J. Thomas, P. Asfar, C. Szabo, P. Moller, F. Gebhard, M. Georgieff, E. Calzia, P. Radermacher, K. Wagner, Cardiopulmonary, histologic, and inflammatory effects of intravenous Na2S after blunt chest traumainduced lung contusion in mice, J. Trauma 71 (2011) 1659-1667.
48. R.C. Francis, K. Vaporidi, K.D. Bloch, F. Ichinose, W.M. Zapol, Protective and detrimental effects of sodium sulfide and hydrogen sulfide in murine ventilator-induced lung injury, Anesthesiology 115 (2011) 1012-1021.
49. H. Aslami, A. Heinen, J.J.T.H. Roelofs, C.J. Zuurbier, M.J. Schultz, N.P. Juffermans, Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury, Intensive Care Med. 36 (2010) 1946-1952.
50. S. Faller, S.W. Ryter, A.M. Choi, T. Loop, R. Schmidt, A. Hoetzel, Inhaled hydrogen sulfide protects against ventilator-induced lung injury, Anesthesiology 113 (2010) 104-115.
51. H. Aslami, C.J.P. Beurskens, F.M. de Beer, M.T. Kuipers, J.J.T.H. Roelofs, M.A. Hegeman, K.F. Van der Sluijs, M.J. Schultz, N.P. Juffermans, A short course of infusion of a hydrogen sulfide-donor attenuates endotoxemia induced organ injury via stimulation of anti-inflammatory pathways, with no additional protection from prolonged infusion, Cytokine 61 (2013) 614-621.
52. K. Shirozu, K. Tokuda, E. Marutani, D. Lefer, R. Wang, F. Ichinose, Cystathionine γ-lyase deficiency protects mice from galactosamine/ lipopolysaccharide-induced acute liver failure, Antioxid. Redox Signal. (2013), http://dx.doi.org/10.1089/ars.2013.5354 [Epub ahead of print].
53. S. Faller, K.K. Zimmermann, K.M. Strosing, H. Engelstaedter, H. Buerkle, R. Schmidt, S.G. Spassov, A. Hoetzel, Inhaled hydrogen sulfide protects against lipopolysaccharide-induced acute lung injury in mice, Med. Gas Res. 2 (2012) 26.
54. K. Tokuda, K. Kida, E. Marutani, E. Crimi, M. Bougaki, A. Khatri, H. Kimura, F. Ichinose, Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice, Antioxid. Redox Signal. 17 (2012) 11-21.
55. L. Li, M. Salto-Tellez, C.H. Tan, M. Whiteman, P.K. Moore, GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat, Free Radic. Biol. Med. 47 (2009) 103-113.
56. L. Li, M. Whiteman, P.K. Moore, Dexamethasone inhibits lipopolysaccharideinduced hydrogen sulphide biosynthesis in intact cells and in an animal model of endotoxic shock, J. Cell Mol. Med. 13 (2009) 2684-2692.
57. G.S. Oh, H.O. Pae, B.S. Lee, B.N. Kim, J.M. Kim, H.R. Kim, S.B. Jeon, W.K. Jeon, H.J. Chae, H.T. Chung, Hydrogen sulfide inhibits nitric oxide production and nuclear factor-B via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide, Free Radic. Biol. Med. 41 (2006) 106-119.
58. M. Collin, F.B. Anuar, O. Murch, M. Bhatia, P.K. Moore, C. Thiemermann, Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia, Br. J. Pharmacol. 146 (2005) 498-505.
59. L. Li, M. Bhatia, Y.Z. Zhu, Y.C. Zhu, R.D. Ramnath, Z.J. Wang, F.B. Anuar, M. Whiteman, M. Salto-Tellez, P.K. Moore, Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse, FASEB J 19 (2005) 1196-1198.
60. J.N. Sidhapuriwala, A. Hegde, A.D. Ang, Y.Z. Zhu, M. Bhatia, Effects of Spropargyl- cysteine (SPRC) in caerulein-induced acute pancreatitis in mice, PLoS One 7 (2012) e32574.
61. R. Tamizhselvi, P. Shrivastava, Y.H. Koh, H. Zhang, M. Bhatia, Preprotachykinin-A gene deletion regulates hydrogen sulfide-induced tolllike receptor 4 signaling pathway in cerulein-treated pancreatic acinar cells, Pancreas 40 (2011) 444-452.
62. J.N. Sidhapuriwala, S.W. Ng, M. Bhatia, Effects of hydrogen sulfide on inflammation in caerulein-induced acute pancreatitis, J. Inflamm. (Lond.) 6 (2009) 35.
63. R. Tamizhselvi, P.K. Moore, M. Bhatia, Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury, Pancreas 36 (2008) e24-e31.
64. H. Aslami, W.P. Pulskens, M.T. Kuipers, A.P. Bos, A.B.P. van Kuilenburg, R.J.A. Wanders, J. Roelofsen, J.J.T.H. Roelofs, R.P. Kerindongo, C.J. P Beurskens, M.J. Schultz, W. Kulik, N.C. Weber, N.P. Juffermans, Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energetic status, PLoS One 8 (2013) e63497.
65. 2S during resuscitated, hyperdynamic murine septic shock, Shock 35 (2011) 396-402.
66. ATP channel activation, Am. J. Respir. Crit. Care Med. 182 (2010) 360-368.
67. H. Zhang, S.M. Moochhala, M. Bhatia, Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis, J. Immunol. 181 (2008) 4320-4331.
68. H. Zhang, L. Zhi, S.M. Moochhala, P.K. Moore, M. Bhatia, Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis, J. Leukoc. Biol. 82 (2007) 894-905.
69. H. Zhang, A. Hegde, S.W. Ng, S. Adhikari, S.M. Moochhala, M. Bhatia, Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury, J. Immunol. 179 (2007) 4153-4160.
70. H. Zhang, L. Zhi, P.K. Moore, M. Bhatia, Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse, Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2006) L1193-L1201.
71. J. Zhang, S.W. Sio, S. Moochhala, M. Bhatia, Role of hydrogen sulfide in severe burn injury-induced inflammation in mice, Mol. Med. 16 (2010) 417-424.
72. A. Esechie, P. Enkhbaatar, D.L. Traber, C. Jonkam, M. Lange, A. Hamahata, C. Djukom, E.B. Whorton, H.K. Hawkins, L.D. Traber, C. Szabo, Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- And smoke-induced acute lung injury, Br. J. Pharmacol. 158 (2009) 1442-1453.
73. A. Esechie, L. Kiss, G. Olah, E.M. Horvath, H. Hawkins, C. Szabo, D.L. Traber, Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation, Clin. Sci. (Lond) 115 (2008) 91-97.
74. S. Mani, H. Li, A. Untereiner, L. Wu, G. Yang, R.C. Austin, J.D. Dickhout, Š. Lhotak, Q.H. Meng, R. Wang, Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis, Circulation 127 (2013) 2523-2534.
75. K. Wang, S. Ahmad, M. Cai, J. Rennie, T. Fujisawa, F. Crispi, J. Baily, M.R. Miller, M. Cudmore, P.W. Hadoke, R. Wang, E. Gratacos, I.A. Buhimschi, C.S. Buhimschi, A. Ahmed, Dysregulation of hydrogen sulfide (H2S) producing enzyme cystathionine (-lyase (CSE) contributes to maternal hypertension and placental abnormalities in preeclampsia, Circulation 127 (2013) 2514-2522.
76. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase, Science 322 (2008) 587-590.
77. 2S donor sodium hydrosulfide in diabetic nephropathy, Clin. Exp. Nephrol. 17 (2013) 32-40.
78. M.A. Aminzadeh, N.D. Vaziri, Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease, Nephrol. Dial. 27 (2012) 498-504.
79. Y. Chen, R. Wang, The message in the air: hydrogen sulfide metabolism in chronic respiratory diseases, Respir. Physiol. Neurobiol. 184 (2012) 130-138.
80. W. Han, Z. Dong, C. Dimitropoulou, Y. Su, Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice, Antioxid. Redox Signal. 15 (2011) 2121-2134.
81. Y.H. Chen, W.Z. Yao, B. Geng, Y.L. Ding, M. Lu, M.W. Zhao, C.S. Tang, Endogenous hydrogen sulfide in patients with COPD, Chest 128 (2005) 3205- 3211.
82. G.K. Kolluru, X. Shen, S.C. Bir, C.G. Kevil, Hydrogen sulfide chemical biology: pathophysiological roles and detection, Nitric Oxide 35C (2013) 5-20.
83. K.R. Olson, A practical look at the chemistry and biology of hydrogen sulfide, Antioxid. Redox Signal. 17 (2012) 32-44.
84. X. Shen, E.A. Peter, S. Bir, R. Wang, C.G. Kevil, Analytical measurement of discrete hydrogen sulfide pools in biological specimens, Free Radic. Biol. Med. 52 (2012) 2276-2283.
85. X. Shen, C.B. Pattillo, S. Pardue, S.C. Bir, R. Wang, C.G. Kevil, Measurement of plasma hydrogen sulfide in vivo and in vitro, Free Radic. Biol. Med. 50 (2011) 1021-1031.
86. M.N. Hughes, M.N. Centelles, K.P. Moore, Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: A review, Free Radic. Biol. Med. 47 (2009) 1346-1353.
87. M.A. Insko, T.L. Deckwerth, P. Hill, C.F. Toombs, C. Szabo, Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide, Br. J. Pharmacol. 157 (2009) 944-951.
88. C.F. Toombs, M.A. Insko, E.A. Wintner, T.L. Deckwerth, H. Usansky, K. Jamil, B. Goldstein, M. Cooreman, C. Szabo, Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide, Br. J. Clin. Pharmacol. 69 (2010) 626-636.
89. J. Furne, A. Saeed, M.D. Levitt, Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values, Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 (2008) R1479-R1485.
90. E.R. DeLeon, G.F. Stoy, K.R. Olson, Passive loss of hydrogen sulfide in biological experiments, Anal. Biochem. 421 (2012) 203-207.
91. M. Groeger, J. Matallo, O. McCook, F. Wagner, U. Wachter, O. Bastian, S. Gierer, V. Reich, B. Stahl, M. Huber-Lang, C. Szabo, M. Georgieff, P. Radermacher, E. Calzia, K. Wagner, Temperature and cell-type dependency of sulfide effects on mitochondrial respiration, Shock 38 (2012) 367-374.
92. K. Baumgart, F. Wagner, M. Groger, S. Weber, E. Barth, J.A. Vogt, U. Wachter, M. Huber-Lang, M.W. Knoferl, G. Albuszies, M. Georgieff, P. Asfar, C. Szabo, E. Calzia, P. Radermacher, V. Simkova, Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice, Crit. Care Med. 38 (2010) 588-595.
93. L. Li, M. Whiteman, Y.Y. Guan, K.L. Neo, Y. Cheng, S.W. Lee, Y. Zhao, R. Baskar, C.H. Tan, P.K. Moore, Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide, Circulation 117 (2008) 2351-2360.
94. M. Whiteman, L. Li, P. Rose, C.H. Tan, D.B. Parkinson, P.K. Moore, The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages, Antioxid. Redox Signal. 12 (2010) 1147-1154.
95. N.L. Whitfield, E.L. Kreimier, F.C. Verdial, N. Skovgaard, K.R. Olson, Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling, Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R1930-R1937.
96. E.A. Wintner, T.L. Deckwerth, W. Langston, A. Bengtsson, D. Leviten, P. Hill, M.A. Insko, R. Dumpit, E. VandenEkart, C.F. Toombs, C. Szabo, A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood, Br. J. Pharmacol. 160 (2010) 941-957.
97. S. Kage, S. Kashimura, H. Ikeda, K. Kudo, N. Ikeda, Fatal and nonfatal poisoning by hydrogen sulfide at an industrial waste site, J. Forensic Sci. 47 (2002) 652-655.
98. Y.H. Chen, P.P. Wang, X.M. Wang, Y.J. He, W.Z. Yao, Y.F. Qi, C.S. Tang, Involvement of endogenous hydrogen sulfide in airway responsiveness and inflammation of rat lung, Cytokines 53 (2011) 334-341.
99. R. Wu, W.Z. Yao, Y.H. Chen, B. Geng, C.S. Tang, Plasma level of endogenous hydrogen sulfide in patients with acute asthma, Beijing Da Xue Xue Bao 40 (2008) 505-508.
100. Y.H. Chen, W.Z. Yao, J.Z. Gao, B. Geng, P.P. Wang, C.S. Tang, Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections, Respirology 14 (2009) 746-752.
101. T. Goslar, T. Marš, M. Podbregar, Total plasma sulfide as a marker of shock severity in nonsurgical adult patients, Shock 36 (2011) 350-355.
102. J. Saito, Q. Zhang, C. Hui, P. Macedo, D. Gibeon, A. Menzies-Gow, P.K. Bhaysar, K.F. Chung, Sputum hydrogen sulfide as a novel biomarker of obstructive neutrophilic asthma, J. Allergy Clin. Immunol. 131 (2013). 232-234.e1-3.
103. R. Wang, Physiological implications of hydrogen sulfide: A whiff exploration that blossomed, Physiol. Rev. 92 (2012) 791-896.
104. N. Wu, Y.L. Siow, O. Kamin, Ischemia/reperfusion reduces transcription factor Sp1-mediated cystathionine-synthase expression in the kidney, J. Biol. Chem. 285 (2010) 18225-18233.
105. M. Fu, W. Zhang, G. Ynag, R. Wang, Is cystathionine gamma-lyase protein expressed in the heart?, Biochem Biophys. Res. Commun. 428 (2012) 469- 474.
106. J. Seok, H.S. Warren, A.G. Cuenca, M.N. Mindrinos, H.V. Baker, W. Xu, D.R. Richards, G.P. McDonald-Smith, H. Gao, L. Hennessy, C.C. Finnerty, C.M. Lopez, S. Honari, E.E. Moore, J.P. Minei, J. Cuschieri, P.E. Bankey, J.L. Johnson, J. Sperry, A.B. Nathens, T.R. Billiar, M.A. West, M.G. Jeschke, M.B. Klein, R.L. Gamelli, N.S. Gibran, B.H. Brownstein, C. Miller-Graziano, S.E. Calvano, P.H. Mason, J.P. Cobb, L.G. Rahme, S.F. Lowry, R.V. Maier, L.L. Moldawer, D.N. Herndon, R.W. Davis, W. Xiao, R.G. Tompkins, Inflammation and host response to injury, large scale collaborative research program, genomic responses in mouse models poorly mimic human inflammatory diseases, Proc. Natl. Acad. Sci. USA 110 (2013) 3507-3512.
107. M.N. Simmons, R. Brandina, A.V. Hernandez, I.S. Gill, Surgical management of bilateral synchronous kidney tumors: functional and oncological outcomes, J. Urol. 184 (2010) 865-872.
108. W. Lieberthal, S.K. Nigam, Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable, Am. J. Physiol. Renal Physiol. 278 (2000). F1-F1.2.
109. K.R. Olson, A theoretical examination of hydrogen sulfide metabolism and its potential in autocrine/paracrine oxygen sensing, Respir. Physiol. Neurobiol. 186 (2013) 173-179.
110. M. Fu, W. Zhang, L. Wu, G. Yang, H. Li, R. Wang, Hydrogen sulfide (H2S) metabolism in mitochondria and ist regulatory role in energy production, Proc. Natl. Acad. Sci. USA 109 (2012) 2943-2948.
111. H. Teng, B. Wu, K. Zhao, G. Yang, L. Wu, R. Wang, Oxygen-sensitive mitochdondrial accumulation of cystathionine-synthase mediated by Lon protease, Proc. Natl. Acad. Sci. USA 110 (2013) 12679-12684.
112. H.K. Eltzschig, P. Carmeliet, Hypoxia and inflammation, N. Engl. J. Med. 364 (2011) 656-665.
113. V. Rontgen, R. Blakytny, R. Matthys, M. Landauer, T. Wehner, M. Gockelmann, P. Jermendy, M. Amling, T. Schinke, L. Claes, A. Ignatius, Fracture healing in mice under controlled rigid and flexible conditions using an adjustable external fixator, J. Orthop. Res. 28 (2010) 1456-1462.
114. M. Groger, A. Scheuerle, F. Wagner, F. Simon, J. Matallo, O. McCook, A. Seifritz, B. Stahl, U. Wachter, J.A. Vogt, P. Asfar, M. Matejovic, P. Moller, L. Lampl, H. Bracht, E. Calzia, M. Georgieff, P. Radermacher, W. Stahl, Effects of pretreatment hypothermia during resuscitated porcine hemorrhagic shock, Crit. Care Med. 41 (2013) e105-e117.
115. B.L. Predmore, M.J. Alendy, K.I. Ahmed, C. Leeuwenburgh, D. Julian, The hydrogen sulfide signaling system: changes during aging and the benefits of caloric restriction, Age (Dordr). 32 (2010) 467.
116. T. Thim, M.K. Hagensen, L. Drouet, C. Bal Dit Sollier, M. Bonneau, J.F. Granada, L.B. Nielsen, W.P. Paaske, H.E. Botker, E. Falk, Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: A model for preclinical studies, EuroIntervention 6 (2010) 261-268.
117. S. Matějkova, A. Scheuerle, F. Wagner, O. McCook, J. Matallo, M. Groger, A. Seifritz, B. Stahl, B. Vcelar, E. Calzia, M. Georgieff, P. Moller, H. Schelzig, P. Radermacher, F. Simon, Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury, Intensive Care Med. 39 (2013) 497-510.
118. M. Wepler, S. Hafner, A. Scheuerle, M. Reize, M. Groger, F. Wagner, F. Simon, J. Matallo, F. Gottschalch, A. Seifritz, B. Stahl, M. Matejovic, A. Kapoor, P. Moller, E. Calzia, M. Georgieff, U. Wachter, J.A. Vogt, C. Thiemermann, P. Radermacher, O. McCook, Effects of the PPAR-/agonist GW0742 during resuscitated porcine septic shock, Intensive Care Med. Exp. 1 (2013) 9.
119. X. Zhao, S. Bhushan, C. Yang, H. Otsuka, J.D. Stein, A. Pacheco, B. Peng, N.O. Devarie-Baez, H.C. Aguilar, D.J. Lefer, M. Xian, Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury, ACS Chem. Biol. (2013). http://dx.doi.org/10.1021/cb400090d [Epub ahead of print].
120. S.F. Ang, S.M. Moochhala, M. Bhatia, Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis, Crit. Care Med. 38 (2010) 619-628.
121. A. Geng, L. Chang, C. Pan, Y. Qi, J. Zhao, Y. Pang, J. Di, C. Tang, Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol, Biochem. Biophys. Res. Commun. 318 (2004) 756-763.
122. 2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase, Circulation 127 (2013) 1116-1127.
123. P. Asfar, E. Calzia, P. Radermacher, Is pharmacological, H2S-induced "suspended animation" feasible in the ICU? Crit. Care (2014) in press.
124. D.C. Angus, T. van der Poll, Severe sepsis and septic shock, N. Engl. J. Med. 369 (2013) 840-851.